Ravicti (glycerol phenylbutyrate)

pCPA File Number: 20967

Negotiation Status:

Concluded with an LOI

Indication(s):

Urea cycle disorders

Sponsor/Manufacturer:

Horizon Therapeutics Ireland DAC

CDA-AMC Project Number:

SR0497-000

pCPA Engagement Letter Issued:

2017-04-21

Negotiation Process Concluded:

2017-12-12